JP2023507188A5 - - Google Patents
Info
- Publication number
- JP2023507188A5 JP2023507188A5 JP2022537467A JP2022537467A JP2023507188A5 JP 2023507188 A5 JP2023507188 A5 JP 2023507188A5 JP 2022537467 A JP2022537467 A JP 2022537467A JP 2022537467 A JP2022537467 A JP 2022537467A JP 2023507188 A5 JP2023507188 A5 JP 2023507188A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazolo
- pyrimidine
- chlorophenyl
- methyl
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1918815.0A GB201918815D0 (en) | 2019-12-19 | 2019-12-19 | Treatment of cancer |
| GB1918815.0 | 2019-12-19 | ||
| PCT/GB2020/053272 WO2021123798A1 (en) | 2019-12-19 | 2020-12-18 | 1h-pyrazolo[3,4-d]pyrimidine compounds useful for the treatment of platinum-resistant cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507188A JP2023507188A (ja) | 2023-02-21 |
| JP2023507188A5 true JP2023507188A5 (enExample) | 2023-12-25 |
| JP7740804B2 JP7740804B2 (ja) | 2025-09-17 |
Family
ID=69322944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022537467A Active JP7740804B2 (ja) | 2019-12-19 | 2020-12-18 | 白金耐性がんの治療に有用な１ｈ－ピラゾロ［３，４－ｄ］ピリミジン化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230064189A1 (enExample) |
| EP (1) | EP4077329A1 (enExample) |
| JP (1) | JP7740804B2 (enExample) |
| GB (1) | GB201918815D0 (enExample) |
| WO (1) | WO2021123798A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024255830A1 (zh) * | 2023-06-14 | 2024-12-19 | 南京正大天晴制药有限公司 | Akt抑制剂在制备预防或治疗卵巢癌药物中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5274842B2 (ja) * | 2004-12-28 | 2013-08-28 | エグゼリクシス， インコーポレイテッド | 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター（ｐ７０Ｓ６Ｋ、Ａｋｔ−１およびＡｋｔ−２）としての［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジンまたは［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジン化合物 |
| EP2037931A2 (en) * | 2006-04-25 | 2009-03-25 | Astex Therapeutics Limited | Pharmaceutical combinations of pk inhibitors and other active agents |
| CN101970415A (zh) * | 2008-01-09 | 2011-02-09 | 阵列生物制药公司 | 作为AKT蛋白激酶抑制剂的5H-环戊二烯并[d]嘧啶 |
| BRPI0921840A2 (pt) * | 2008-11-11 | 2018-10-09 | Lilly Co Eli | produto compreendendo o composto inibidor de p70 s6 quinase e inibidor de mtor, composto inibidor de p70 s6 quinase e uso do mesmo |
-
2019
- 2019-12-19 GB GBGB1918815.0A patent/GB201918815D0/en not_active Ceased
-
2020
- 2020-12-18 US US17/786,355 patent/US20230064189A1/en active Pending
- 2020-12-18 WO PCT/GB2020/053272 patent/WO2021123798A1/en not_active Ceased
- 2020-12-18 JP JP2022537467A patent/JP7740804B2/ja active Active
- 2020-12-18 EP EP20838201.0A patent/EP4077329A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI620736B (zh) | 使用選擇性ｂｃｌ-２抑制劑之治療方法 | |
| JP6363616B2 (ja) | オートタキシン阻害剤 | |
| JP2021532124A5 (enExample) | ||
| JP2021512143A5 (enExample) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| AR119731A1 (es) | Inhibidores del inflamasoma nlrp3 | |
| CN107635975B (zh) | Dgat2抑制剂 | |
| JP2013530179A (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）感染の処置に使用するためのウレイド−ピラゾール誘導体 | |
| JP2013010792A5 (enExample) | ||
| JP2017502033A5 (enExample) | ||
| RU2009119290A (ru) | Производные гидантоина, используемые в качестве ингибиторов ммр | |
| RU2430923C2 (ru) | Тиазолилдигидрохиназолины | |
| EA020641B1 (ru) | Производные n-(1-фенил-3-алкилпиразол-5-ил)-n'-арилмочевины | |
| JP2015516434A5 (enExample) | ||
| ES2762193T3 (es) | Agonistas de proteína tirosina fosfatasa 1 que contiene dominio de homología Src-2 y métodos de tratamiento usando la misma | |
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| RU2007146798A (ru) | ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА | |
| RU2006126974A (ru) | Амидное производное и лекарственное средство | |
| JP2021502387A5 (enExample) | ||
| JP2008110984A5 (enExample) | ||
| JP2017509694A5 (enExample) | ||
| CA2660529A1 (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| JP2021515004A5 (enExample) | ||
| RU2012147511A (ru) | Применение ингибиторов c-src в комбинации с пиримидиламинобензамидом для лечения лейкоза | |
| US20170007614A1 (en) | Autotaxin inhibitors |